Koyfin Home > Directory > Health Care > Kura Oncology > Long-term Debt / Equity

Kura Oncology Long-term Debt / Equity Chart (KURA)

Kura Oncology annual/quarterly Long-term Debt / Equity from 2016 to 2020.
  • Kura Oncology Long-term Debt / Equity for the quarter ending June 06, 2020 was $4m a 12.05% increase of 0m year over year
  • Kura Oncology Long-term Debt / Equity for the last 12 months ending June 06, 2020 was $4m a 12.05% increase of 0m year over year
  • Kura Oncology Annual Long-term Debt / Equity for 2019 was $3m a -40.59% decrease of -1m from 2018
  • Kura Oncology Annual Long-term Debt / Equity for 2018 was $5m a -49.62% decrease of -2m from 2017
  • Kura Oncology Annual Long-term Debt / Equity for 2017 was $7m a -84.74% decrease of -6m from 2016
Other Ratios Metrics:
  • Kura Oncology Total Debt / Capital for the quarter ending September 09, 2018 was $3m a -135.60% decrease of -5m year over year
  • Kura Oncology Other Liabilities for the quarter ending December 12, 2018 was $0m a -59.86% decrease of 0m year over year
  • Kura Oncology Total Debt / Equity for the quarter ending September 09, 2018 was $4m a -147.66% decrease of -5m year over year
View Chart On Koyfin

Quarterly KURA Long-term Debt / Equity Data

06/2020$4m
03/2020$4m
12/2019$3m
09/2019$3m
06/2019$3m
03/2019$5m
12/2018$5m
09/2018$2m
06/2018$4m
03/2018$4m

Annual KURA Long-term Debt / Equity Data

2019$3m
2018$5m
2017$7m
2016$13m
2014$-14m